newsfilter
← Latest News
GlobeNewswire·

Artelo Biosciences Provides Business Update and Reports 2026 Second Quarter Financial Results

SOLANA BEACH, Calif., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ:ARTL) ("Artelo" or the "Company"), a clinical-stage pharmaceutical company focused on modulating lipid-signaling